Commercial Commentary

Life Sciences Lab / Flex R&D Commentary (Week of August 10, 2026)

Trevor Damyan Founder & Principal Broker

CA DRE #02244836

Former CBRE and Marcus & Millichap Capital Corporation. $1B+ in closed commercial real estate financing across bridge, construction, permanent, and structured debt.

August 10, 2026

Quick answer: Commentary on life sciences lab-flex construction and permanent financing in major biotech clusters (Boston, SF, San Diego, Raleigh-Durham), tenant pre-leasing dynamics, and specialty lender activity.

What would your deal price at today?

Tell us the loan amount and we'll send indicative pricing from our 1,000+ lender network, usually same day. Loans from $2MM.

No obligation. No credit pull. Or call 310.708.0690.

Commercial Commentary

Adaptive Reuse / Conversion Commercial Market (Week of August 03, 2026)

Commentary on adaptive reuse and conversion activity (office-to-multifamily, office-to-life-science, retail-to-self-storage), specialty debt fund pricing, and forward take-out structuring.

Trevor Damyan August 03, 2026

Commercial Commentary

Hospitality RevPAR Recovery and Lender Commentary (Week of July 13, 2026)

Commentary on hospitality RevPAR recovery dynamics by segment (luxury, upscale, select-service, limited-service) and how specialty hospitality lenders are pricing deals.

Trevor Damyan July 13, 2026

Commercial Commentary